Schizophrenia is a mental health condition that demands vigilance. Even with a good response to initial treatment, schizophrenia symptoms often return. A return or worsening of symptoms following ...

The novel PDE10A inhibitor CPL'36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

Antipsychotic medication and psychotherapy are the first-line treatments for schizophrenia, but there are many complementary and integrative therapies that may also be beneficial for improving ...

Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activity against the symptoms of ...

were expected to provide better effectiveness and promote adherence in patients with schizophrenia. This study was implemented to assess the efficacy and safety of once-daily quetiapine XR in ...

Shares in Neurocrine Bioscience took a tumble after the company reported mid-stage data for a key pipeline drug for schizophrenia that failed to impress investors. The 19% after-market selloff ...

She has over 20 years’ experience from the field of MRI and schizophrenia. The author has completed the ICMJE form and declares no conflicts of interest. K.G. Jebsen Centre for Psychosis Research ...